UBS Knock-Out HEN3/ DE000UH4L1Y8 /
13/05/2024 13:23:36 | Chg.+0.070 | Bid13:23:36 | Demandez à13:23:36 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
0.600EUR | +13.21% | 0.600 Bid taille: 50,000 |
0.610 Ask la taille: 50,000 |
HENKEL AG+CO.KGAA VZ... | 87.5808 EUR | 31/12/2078 | Put |
GlobeNewswire
13:15
Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and C...
Newsfile Corp
13:15
Perseverance Metals Strengthens Its Board of Directors, Management and Advisory Teams with the Addit...
GlobeNewswire
13:15
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss First Quarter Fis...
GlobeNewswire
13:07
EnviroGold Global Announces the Appointment of Paul McRae as an Independent Director
GlobeNewswire
13:00
Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Tr...
GlobeNewswire
13:00
Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call
GlobeNewswire
13:00
Bitfarms Announces Acceleration of Previously Announced Termination of CEO and Provides Update on Ne...
GlobeNewswire
13:00
Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page